Your browser doesn't support javascript.
loading
Orbitofrontal control of conduct problems? Evidence from healthy adolescents processing negative facial affect.
Böttinger, Boris William; Baumeister, Sarah; Millenet, Sabina; Barker, Gareth J; Bokde, Arun L W; Büchel, Christian; Quinlan, Erin Burke; Desrivières, Sylvane; Flor, Herta; Grigis, Antoine; Garavan, Hugh; Gowland, Penny; Heinz, Andreas; Ittermann, Bernd; Martinot, Jean-Luc; Martinot, Marie-Laure Paillère; Artiges, Eric; Orfanos, Dimitri Papadopoulos; Paus, Tomás; Poustka, Luise; Fröhner, Juliane H; Smolka, Michael N; Walter, Henrik; Whelan, Robert; Schumann, Gunter; Banaschewski, Tobias; Brandeis, Daniel; Nees, Frauke.
Afiliación
  • Böttinger BW; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany. boris.boettinger@zi-mannheim.de.
  • Baumeister S; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.
  • Millenet S; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.
  • Barker GJ; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Bokde ALW; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
  • Büchel C; University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Martinistr. 52, 20246, Hamburg, Germany.
  • Quinlan EB; Medical Research Council, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Desrivières S; Medical Research Council, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Flor H; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Grigis A; Department of Psychology, School of Social Sciences, University of Mannheim, 68131, Mannheim, Germany.
  • Garavan H; NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France.
  • Gowland P; Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, 05405, USA.
  • Heinz A; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.
  • Ittermann B; Department of Psychiatry and Psychotherapy, Charité, Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, Berlin, Germany.
  • Martinot JL; Freie Universität Berlin, Berlin, Germany.
  • Martinot MP; Humboldt-Universität Zu Berlin, Berlin, Germany.
  • Artiges E; Berlin Institute of Health, Berlin, Germany.
  • Orfanos DP; Physikalisch-Technische Bundesanstalt (PTB), Abbestr. 2-12, Berlin, Germany.
  • Paus T; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany.
  • Poustka L; Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", University Paris Sud, University Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Fröhner JH; Maison de Solenn, Paris, France.
  • Smolka MN; Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", University Paris Sud, University Paris Descartes; Sorbonne Université, Paris, France.
  • Walter H; AP-HP, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France.
  • Whelan R; Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", University Paris Sud, University Paris Descartes, Sorbonne Paris Cité, Orsay, France.
  • Schumann G; Psychiatry Department 91G16, Orsay Hospital, Orsay, France.
  • Banaschewski T; NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France.
  • Brandeis D; Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital and Departments of Psychology and Psychiatry, University of Toronto, Toronto, ON, M6A 2E1, Canada.
  • Nees F; Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, von-Siebold-Str. 5, 37075, Göttingen, Germany.
Eur Child Adolesc Psychiatry ; 31(8): 1-10, 2022 Aug.
Article en En | MEDLINE | ID: mdl-33861383
ABSTRACT
Conduct problems (CP) in patients with disruptive behavior disorders have been linked to impaired prefrontal processing of negative facial affect compared to controls. However, it is unknown whether associations with prefrontal activity during affective face processing hold along the CP dimension in a healthy population sample, and how subcortical processing is affected. We measured functional brain responses during negative affective face processing in 1444 healthy adolescents [M = 14.39 years (SD = 0.40), 51.5% female] from the European IMAGEN multicenter study. To determine the effects of CP, we applied a two-step

approach:

(a) testing matched subgroups of low versus high CP, extending into the clinical range [N = 182 per group, M = 14.44 years, (SD = 0.41), 47.3% female] using analysis of variance, and (b) considering (non)linear effects along the CP dimension in the full sample and in the high CP group using multiple regression. We observed no significant cortical or subcortical effect of CP group on brain responses to negative facial affect. In the full sample, regression analyses revealed a significant linear increase of left orbitofrontal cortex (OFC) activity with increasing CP up to the clinical range. In the high CP group, a significant inverted u-shaped effect indicated that left OFC responses decreased again in individuals with high CP. Left OFC activity during negative affective processing which is increasing with CP and decreasing in the highest CP range may reflect on the importance of frontal control mechanisms that counteract the consequences of severe CP by facilitating higher social engagement and better evaluation of social content in adolescents.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno de la Conducta / Problema de Conducta Tipo de estudio: Clinical_trials Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Eur Child Adolesc Psychiatry Asunto de la revista: PEDIATRIA / PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno de la Conducta / Problema de Conducta Tipo de estudio: Clinical_trials Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Eur Child Adolesc Psychiatry Asunto de la revista: PEDIATRIA / PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania